Brazilian govt to boost generics

18 October 2001

Brazilian national health service doctors are to receive new informationon the value and use of generic drugs, as part of a campaign by the Ministry of Health, the Brazilian Medical Association and the Federal Medical Council aimed at expanding the use of generics among health care professionals.

Information packs, which will go to some 250 doctors, will cover legislation and details of generics registration, as well as quality testing for marketing approval. Information will also be distributed through a web site to help doctors keep up with new drugs.

Health Minister Jose Serra said one of the problems in developing the use of generics was the resistance by pharmacies because their return on these products was lower. Some 400 generic products in 57 therapeutic classes have been registered in Brazil.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight